Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01744197 · ClinicalTrials.gov registry record · Phase 2
Synera Venipuncture Pain
A Phase 2 study, sponsored by US Oncology Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT01744197 is a Phase 2 study that has completed, run by US Oncology Research. The registered enrollment target is 61 participants.
The verdict
NCT01744197, a Phase 2 study, has completed, sponsored by US Oncology Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
Synera, which is a heated topical patch containing both lidocaine and tetracaine, is intended to reduce the pain associated with venipuncture and superficial dermatologic procedures by numbing the skin. This study will test the effectiveness of the Synera lidocaine/tetracaine patch when administered for 30 ± 5 minutes to provide dermal anesthesia in adult oncology patients undergoing venipuncture as part of their care, for treatment or diagnostics (laboratory or imaging). Compared to the use of the placebo patch, this study hypothesizes that the difference of 1 cm on the 0-10 visual analogue scale (VAS) will be observed 30 minutes after the use of the Synera patch. Pain intensity will be assessed by a 0-10 VAS
Interventions
- DRUG Synera (lidocaine 70mg/tetracaine 70mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01744197
The ClinicalTrials.gov registry entry for NCT01744197 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Oncology Research, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synera (lidocaine 70mg/tetracaine 70mg) is the first listed.
NCT01744197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01744197 about?
NCT01744197 is a clinical study titled "Synera Venipuncture Pain". Synera, which is a heated topical patch containing both lidocaine and tetracaine, is intended to reduce the pain associated with venipuncture and superficial dermatologic procedures by numbing the skin. This study will test the effectiveness of the Synera lidocaine/tetracaine patch when administered...
What is the current status of trial NCT01744197?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2013-01. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01744197?
The interventions under investigation include: Synera (lidocaine 70mg/tetracaine 70mg) (DRUG).
Who is sponsoring clinical trial NCT01744197?
This trial is sponsored by US Oncology Research, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.